These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 29985647)

  • 1. Increasing Prevalence of HIV Pretreatment Drug Resistance in Women But Not Men in Rural Uganda During 2005-2013.
    McCluskey SM; Lee GQ; Kamelian K; Kembabazi A; Musinguzi N; Bwana MB; Muzoora C; Haberer JE; Hunt PW; Martin JN; Boum Y; Bangsberg DR; Harrigan PR; Siedner MJ
    AIDS Patient Care STDS; 2018 Jul; 32(7):257-264. PubMed ID: 29985647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study.
    Hamers RL; Wallis CL; Kityo C; Siwale M; Mandaliya K; Conradie F; Botes ME; Wellington M; Osibogun A; Sigaloff KC; Nankya I; Schuurman R; Wit FW; Stevens WS; van Vugt M; de Wit TF;
    Lancet Infect Dis; 2011 Oct; 11(10):750-9. PubMed ID: 21802367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High levels of pre-treatment HIV drug resistance and treatment failure in Nigerian children.
    Boerma RS; Boender TS; Sigaloff KC; Rinke de Wit TF; van Hensbroek MB; Ndembi N; Adeyemo T; Temiye EO; Osibogun A; Ondoa P; Calis JC; Akanmu AS
    J Int AIDS Soc; 2016; 19(1):21140. PubMed ID: 27836020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pretreatment resistance mutations and treatment outcomes in adults living with HIV-1: a cohort study in urban Malawi.
    Neuhann F; de Forest A; Heger E; Nhlema A; Scheller C; Kaiser R; Steffen HM; Tweya H; Fätkenheuer G; Phiri S
    AIDS Res Ther; 2020 May; 17(1):22. PubMed ID: 32434561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survey of Pretreatment HIV Drug Resistance and Genetic Transmission Network Analysis Among HIV Patients in a High Drug-Use Area of Southwest China.
    Liu L; Dong A; Liao L; Feng Y; Shao Y; Liang S; Ruan Y; Xing H
    Curr HIV Res; 2019; 17(6):441-451. PubMed ID: 31778107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-treatment drug resistance and HIV-1 genetic diversity in the rural and urban settings of Northwest-Cameroon.
    Fokam J; Takou D; Teto G; Nforbih SE; Kome OP; Santoro MM; Ngoufack ES; Eyongetah M; Palmer D; Fokunang ET; Fokunang CN; Colizzi V; Perno CF; Ndjolo A
    PLoS One; 2020; 15(7):e0235958. PubMed ID: 32692778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pretreatment HIV Drug Resistance and Virologic Outcomes to First-Line Antiretroviral Therapy in Peru.
    Soria J; Mugruza R; Levine M; León SR; Arévalo J; Ticona E; Beck IA; Frenkel LM
    AIDS Res Hum Retroviruses; 2019 Feb; 35(2):150-154. PubMed ID: 30560685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the management of pretreatment HIV drug resistance by oligonucleotide ligation assay: a randomised controlled trial.
    Chung MH; McGrath CJ; Beck IA; Levine M; Milne RS; So I; Andersen N; Dross S; Coombs RW; Chohan B; Yatich N; Kiptinness C; Sakr SR; Kiarie JN; Frenkel LM
    Lancet HIV; 2020 Feb; 7(2):e104-e112. PubMed ID: 31818716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diversity of HIV-1 genotypes and high prevalence of pretreatment drug resistance in newly diagnosed HIV-infected patients in Shanghai, China.
    Wang Z; Zhang M; Zhang R; Liu L; Shen Y; Wang J; Lu H
    BMC Infect Dis; 2019 Apr; 19(1):313. PubMed ID: 30961560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretreatment HIV drug resistance among adults initiating ART in Namibia.
    Taffa N; Roscoe C; Sawadogo S; De Klerk M; Baughman AL; Wolkon A; Mutenda N; DeVos J; Zheng DP; Wagar N; Prybylski D; Yang C; Hamunime N; Agolory S; Raizes E
    J Antimicrob Chemother; 2018 Nov; 73(11):3137-3142. PubMed ID: 30137412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV pretreatment drug resistance among cisgender MSM and transgender women from Lima, Peru.
    Trebelcock WL; Lama JR; Duerr A; Sanchez H; Cabello R; Gilada T; Segura P; Reisner SL; Mayer KH; Mullins J; Bender Ignacio RA
    J Int AIDS Soc; 2019 Nov; 22(11):e25411. PubMed ID: 31773888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High levels of pretreatment and acquired HIV drug resistance in Nicaragua: results from the first nationally representative survey, 2016.
    Girón-Callejas A; García-Morales C; Mendizabal-Burastero R; Román M; Tapia-Trejo D; Pérez-García M; Quiroz-Morales VS; Juárez SI; Ravasi G; Vargas C; Gutiérrez R; Romero L; Solórzano A; Sajquim E; Northbrook S; Ávila-Ríos S; Reyes-Terán G
    J Int AIDS Soc; 2019 Dec; 22(12):e25429. PubMed ID: 31860167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretreatment HIV drug resistance increases regimen switches in sub-Saharan Africa.
    Boender TS; Hoenderboom BM; Sigaloff KC; Hamers RL; Wellington M; Shamu T; Siwale M; Labib Maksimos EE; Nankya I; Kityo CM; Adeyemo TA; Akanmu AS; Mandaliya K; Botes ME; Ondoa P; Rinke de Wit TF
    Clin Infect Dis; 2015 Dec; 61(11):1749-58. PubMed ID: 26240203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 drug resistance before initiation or re-initiation of first-line ART in eight regions of Mexico: a sub-nationally representative survey.
    Ávila-Ríos S; García-Morales C; Valenzuela-Lara M; Chaillon A; Tapia-Trejo D; Pérez-García M; López-Sánchez DM; Maza-Sánchez L; Del Arenal-Sánchez SJ; Paz-Juárez HE; Quiroz-Morales VS; Mehta SR; Smith DM; León-Juárez EA; Magis-Rodríguez C; Reyes-Terán G;
    J Antimicrob Chemother; 2019 Apr; 74(4):1044-1055. PubMed ID: 30597094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinically relevant thresholds for ultrasensitive HIV drug resistance testing: a multi-country nested case-control study.
    Inzaule SC; Hamers RL; Noguera-Julian M; Casadellà M; Parera M; Kityo C; Steegen K; Naniche D; Clotet B; Rinke de Wit TF; Paredes R;
    Lancet HIV; 2018 Nov; 5(11):e638-e646. PubMed ID: 30282603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and Correlates of Pre-Treatment HIV Drug Resistance among HIV-Infected Children in Ethiopia.
    Tadesse BT; Tsai O; Chala A; Chaka TE; Eromo T; Lapointe HR; Baraki B; Shahid A; Tadesse S; Makonnen E; Brumme ZL; Aklillu E; Brumme CJ
    Viruses; 2019 Sep; 11(9):. PubMed ID: 31546824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 drug resistance surveillance in antiretroviral treatment-naive individuals from a reference hospital in Guatemala, 2010-2013.
    Avila-Ríos S; García-Morales C; Garrido-Rodríguez D; Tapia-Trejo D; Girón-Callejas AC; Mendizábal-Burastero R; Escobar-Urias IY; García-González BL; Navas-Castillo S; Pinzón-Meza R; Mejía-Villatoro CR; Reyes-Terán G
    AIDS Res Hum Retroviruses; 2015 Apr; 31(4):401-11. PubMed ID: 25347163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moderate-to-High Levels of Pretreatment HIV Drug Resistance in KwaZulu-Natal Province, South Africa.
    Chimukangara B; Kharsany ABM; Lessells RJ; Naidoo K; Rhee SY; Manasa J; Gräf T; Lewis L; Cawood C; Khanyile D; Diallo K; Ayalew KA; Shafer RW; Hunt G; Pillay D; Abdool SK; de Oliveira T
    AIDS Res Hum Retroviruses; 2019 Feb; 35(2):129-138. PubMed ID: 30430843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 pretreatment drug resistance negatively impacts outcomes of first-line antiretroviral treatment.
    Hermans LE; Hofstra LM; Schuurman R; Ter Heine R; Burger DM; Talboom SAJ; De Jong D; Tempelman HA; Venter WDF; Nijhuis M; Wensing AMJ
    AIDS; 2022 Jun; 36(7):923-931. PubMed ID: 35113046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pretreatment HIV drug resistance results in virological failure and accumulation of additional resistance mutations in Ugandan children.
    Kityo C; Boerma RS; Sigaloff KCE; Kaudha E; Calis JCJ; Musiime V; Balinda S; Nakanjako R; Boender TS; Mugyenyi PN; Rinke de Wit TF
    J Antimicrob Chemother; 2017 Sep; 72(9):2587-2595. PubMed ID: 28673027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.